Skip to main content
. Author manuscript; available in PMC: 2013 Apr 8.
Published in final edited form as: Circulation. 2011 Sep 6;124(13):1414–1425. doi: 10.1161/CIRCULATIONAHA.111.026542

Table 1.

Clinical Electocardiographic, Angiographic, Intravascular ultrasound and MRI Findings

All Patients (n=50) Plaque Disruption (n=16) No Plaque Disruption (n=26) p LGE (n=17) No LGE (n=27) p STE (n=11) No STE (n=39) p Abnormal T2 (n=17) Normal T2 (n=15) p
Age (mean±SD) 56.9±12.8 60.9±11.4 53.5±13.7 0.07 55.4±14.3 57.3±12.7 0.65 52.5±14.7 58.2±12.0 0.26 59.5±14.1 52.0±12.4 0.12
Troponin, ng/mL (median, IQR) 1.60 (0.44-4.31) 1.49 (0.53,2.71) 0.96 (0.14,4.13) 0.75 3.13 (1.90,40.3) 1.10 (0.37,1.98) 0.01 1.40 (2.20,4.55) 1.32 (0.16, 4.13) 0.32 5.97(1.96, 11.0) 0.66(0.16, 1.30) <0.001
HTN (%) 30(60%) 8(50%) 17(65%) 0.35 15(88%) 16(59%) 0.05 8(73%) 22(56%) 0.47 12(71%) 12(80%) 0.61
DM (%) 16(32%) 7(44%) 8(31%) 0.35 6(35%) 8(30%) 0.75 3(27%) 14(36%) 0.17 6(35%) 6(40%) 0.99
Prior MI (%) 6(12%) 1(6%) 4(15%) 0.69 2(12%) 4(15%) 0.73 2(18%) 4(10%) 0.85 3(18%) 2(13%) 0.99
Smoking (%) 9(18%) 3(19%) 7(27%) 0.54 4 24%) 4(15%) 0.69 2(18%) 8(21%) 0.80 3(18%) 2(13%) 0.99
BMI (median, IQR) 26.2 (24.4,28.4) 27.6 (24.3,33.7) 0.52 27.4 (24,28.8) 26.4 (26.4,30.7) 0.78 25.1 (23.1,27.3) 27.0 (24.4, 31.4) 0.11 27.1 (24.8,28.1) 31.4 (25.4,36.3) 0.15
ECG Findings
ST Elevation 11(22%) 2(13%) 4(15%) 5(29%) 5(19%) 0.47 11(100%) 0(0%) - 4(24%) 3(20%) 0.99
ST Depression 7(14%) 2(13%) 2(8%) 0.63 0(0%) 3(11%) 0.23 0(0%) 4(11%) 0.56 1(6%) 2(13%) 0.59
T Wave inversion 22(44%) 10(63%) 10(38%) 0.19 7(41%) 14(52%) 0.36 5(45%) 17(44%) 0.42 9(53%) 4(27%) 0.14
LV Wall Motion
Any abnormal segment 26(52%) 7(44%) 14(54%) 0.79 6(35%) 7(26%) 0.05 4(29%) 20(52%) 0.51 13(77%) 5(33%) 0.03
LVEF (median, IQR) 60(43,63) 56(49,62) 60(55,62) 0.66 55(42,60) 60(48,65) 0.57 55(38,60) 60(48,64) 0.17 55(45,60) 64(55,68) 0.06
Cath findings
Worst % angiographic stenosis (median, IQR) 20(0,40) 40(30,45) 0(0,20) <0.001 15(0,30) 30(0,40) 0.16 30 (0,45) 20 (0,37.5) 0.47 30(15,40) 10(0,30) 0.10
Absence of atherosclerosis 15(30%) 0(0%) 13(50%) 6(18%) 6(22%) 0.28 4(36%) 11(28%) 0.73 7(41%) 11(73%) 0.09
IVUS Findings N=42 N=42 N=36 N=42 N=25
Plaque Disruption 16(38%) - - - 1(6%) 13(48%) 0.003 2(13%) 12(34%) 0.13 6(43%) 2(17%) 0.20
CMR findings N=44 N=36 N=44 N=44 N=32
LGE (any) LGE type 17(39%) 1(7%) 11(50%) 0.03 17(39%) 27(61%) - 7(47%) 15(43%) 0.80 8(47%) 4(27%) 0.29
Transmural 9 1 6 0.32 9 0 - 5 3 0.01 4 3 0.99
Subendocardial 1 0 0 1 1 0 - 1 0 1.0 0 1 0.49
Centromyocardial 2 0 2 0.67 2 0 - 0 2 1.0 1 0 0.99
Subepicardial 1 0 1 1 1 0 - 0 1 1.0 1 0 0.99
“Mixed” pattern 4 0 2 0.70 4 0 - 1 3 0.99 2 0 0.49
T2 signal hyperintensity N=32 N=25 N=32 N=32
Present 17(53%) 6(75%) 7(41%) 0.20 8(67%) 9(45%) 0.29 4(57%) 13(52%) 1 - - -
Absent 15(47%) 2(25%) 10(59%) 4(33%) 11(55%) 3(43%) 12(48%) - - -
Timing of Procedures N=50 N=16 N=26 N=17 N=27 N=11 N=39 N=17 N=15
MI to IVUS (days) 2(1,2) 3.5(1,5) 2(1,4) 0.18 2(1,3.5) 2.5(1,5) 0.54 1(1,1) 2(1,5) 0.01 2(1,5) 2(1,5) 0.86
MI to CMR (days) 6(4,8) 6(4,7) 6(2,11) 0.74 6.5(3,10) 6(3,7) 0.41 4(3,6) 6(3,8) 0.25 6.5(4 9) 6(4.5,9) 0.54

BMI=body mass index; ECG=electrocardiogram; LV=left ventricle; LVEF=left ventricular ejection fraction; CMR=cardiac magnetic resonance imaging; DM=diabetes mellitus; HTN=hypertension; IQR=interquartile range; IVUS=intravascular ultrasound; LGE=late gadolinium enhancement; MI=myocardial infarction